TGFbeta activates mitogen- and stress-activated protein kinase-1 (MSK1) to attenuate cell death
Lars P van der Heide1, Maarten van Dinther, Aristidis Moustakas
1Department of Molecular Cell Biology, and Centre for Biomedical Genetics, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands. lars.vdh@LICR.uu.se
Abstract:
Transforming growth factor-β (TGFβ) binding to its receptor leads to intracellular phosphorylation of Smad2 and Smad3, which oligomerize with Smad4. These complexes accumulate in the nucleus and induce gene transcription. Here we describe mitogen- and stress-activated kinase 1 (MSK1) as an antagonist of TGFβ-induced cell death. Induction of MSK1 activity by TGFβ depends on Smad4 and p38 MAPK activation. Knockdown of GADD45, a Smad4-induced upstream regulator of p38 MAPK prevents TGFβ-induced p38 and MSK1 activity. MSK1 functionally regulates pro-apoptotic BH3-only BCL2 proteins, as MSK1 knockdown reduces Bad phosphorylation and enhances Noxa and Bim expression, leading to enhanced TGFβ-induced caspase-3 activity and cell death. This finding suggests that MSK1 represents a pro-survival pathway bifurcating downstream of p38 and antagonizes the established pro-apoptotic p38 MAPK function. Furthermore, EGF could reverse all the effects observed after MSK1 knockdown. Monitoring the status of MSK1 activity in cancer promises new therapeutic targets as inactivating both MSK1 and EGF signaling may (re)-sensitize cells to TGFβ-induced cell death.
Insights
Mitogen- and stress-activated kinase 1 (MSK1) acts as a survival pathway, opposing transforming growth factor-beta (TGFβ)-induced cell death. MSK1 inactivation enhances TGFβ-induced apoptosis, suggesting therapeutic potential in cancer.
Area of Science:
- Cellular signaling pathways
- Molecular mechanisms of apoptosis
- Cancer biology
Background:
- Transforming growth factor-beta (TGFβ) signaling is crucial for cellular processes, including apoptosis.
- Smad proteins mediate TGFβ-induced gene transcription.
- The role of mitogen- and stress-activated kinase 1 (MSK1) in TGFβ signaling and cell death remains incompletely understood.
Purpose of the Study:
- To investigate the role of MSK1 as a regulator of TGFβ-induced cell death.
- To elucidate the molecular mechanisms by which MSK1 influences apoptosis.
- To explore the potential of targeting MSK1 and EGF signaling in cancer therapy.
Main Methods:
- Investigated MSK1 activity in response to TGFβ stimulation.
- Utilized knockdown of GADD45 and MSK1 to assess their impact on signaling pathways.
- Analyzed the phosphorylation status of pro-apoptotic BH3-only BCL2 proteins (Bad, Noxa, Bim).
- Measured caspase-3 activity to quantify apoptosis.
- Examined the effects of Epidermal Growth Factor (EGF) on MSK1 knockdown phenotypes.
Main Results:
- TGFβ induces MSK1 activity, dependent on Smad4 and p38 MAPK.
- GADD45 knockdown abrogates TGFβ-induced p38 and MSK1 activation.
- MSK1 knockdown enhances TGFβ-induced apoptosis by reducing Bad phosphorylation and increasing Noxa and Bim expression.
- MSK1 acts as a pro-survival pathway downstream of p38 MAPK.
- EGF signaling can reverse the effects of MSK1 knockdown.
Conclusions:
- MSK1 functions as a pro-survival factor that antagonizes TGFβ-induced apoptosis.
- The p38 MAPK pathway bifurcates, with MSK1 promoting survival and other effectors driving apoptosis.
- Targeting MSK1 and EGF signaling may re-sensitize cancer cells to TGFβ-induced death.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
MAPK Signaling Cascades
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
